Finance

Lists
Why is NBTX up ३.४१%?
Dive Deeper
NBTX:NASDAQ
Nanobiotix SA - ADR
US$ २३.६८
+३.४१%
(+०.७८) 1D
अक्टोबर ९, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NBTX...
Open
US$ २३.५१
High
US$ २४.५०
Low
US$ २३.३३
Mkt. cap
१.२१ अरब
Avg. vol.
१.५० लाख
Volume
०.००
52-wk high
US$ ५७.१४
52-wk low
US$ १४.७८
EPS
-US$ १.२२
Beta
०.७४
Shares outstanding
५.०८ करोड
No. of employees
९८
Open
US$ २३.५१
High
US$ २४.५०
Low
US$ २३.३३
Mkt. cap
१.२१ अरब
Avg. vol.
१.५० लाख
Volume
०.००
52-wk high
US$ ५७.१४
52-wk low
US$ १४.७८
EPS
-US$ १.२२
Beta
०.७४
Shares outstanding
५.०८ करोड
No. of employees
९८
News stories
From web sources and news partners
Ideal Investisseur
Ideal Investisseur
·
२ दिन पहिले
35.5% decline in one month for Nanobiotix share, which gains 2%
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA - ADR
CEOLaurent Levy
Employees९८
Founded२००३
Headquarters-
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to NBTX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NBTX in the last 3 months.
Highest
Current US$ २३.६८
US$ ६४.०० (+१७०.२७%)
Average
US$ ४७.०० (+९८.४८%)
Lowest
US$ ३०.०० (+२६.६९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Jeng
Guggenheim
Buy
Maintained
US$ ६४.००
+१७०.३%
09/25/2026
David Dai
UBS
Hold
Maintained
US$ ३०.००
+२६.७%
09/25/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
09/25/2026
Michael Schmidt
Guggenheim
Buy
Reiterated
US$ ३६.००
+५२%
05/05/2026
Jonathan Chang
Leerink Partners
Buy
Maintained
US$ ३७.००
+५६.२%
04/01/2026
Unknown Analyst
Guggenheim
Buy
Maintained
US$ २६.००
+९.८%
02/05/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२९.७८ लाख
२९.७८ लाख
२७.७६ लाख
२७.७६ लाख
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
४२.९३ लाख
४२.९३ लाख
६३.६० लाख
६३.६० लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४५.३३ लाख
४५.३३ लाख
५३.७६ लाख
५३.७६ लाख
Operating expense
८८.२६ लाख
८८.२६ लाख
१.१७ करोड
१.१७ करोड
Total operating expenses
८८.२६ लाख
८८.२६ लाख
१.१७ करोड
१.१७ करोड
Operating income
-५८.४८ लाख
-५८.४८ लाख
-८९.६२ लाख
-८९.६२ लाख
Other non operating income
-८.५० हजार
-८.५० हजार
-१.०० हजार
-१.०० हजार
EBT including unusual items
-९२.९० लाख
-९२.९० लाख
-१.७१ करोड
-१.७१ करोड
EBT excluding unusual items
-८५.६८ लाख
-८५.६८ लाख
-१.६६ करोड
-१.६६ करोड
Income tax expense
-१.५० हजार
-१.५० हजार
८.०० हजार
८.०० हजार
Effective tax rate
०.०२%
०.०२%
-०.०५%
-०.०५%
Other operating expenses
-
-
-
-
Net income
-९२.८९ लाख
-९२.८९ लाख
-१.७१ करोड
-१.७१ करोड
Net profit margin
-३११.९७%
-३११.९७%
-६१७.६९%
-६१७.६९%
Earnings per share
-
-
-
-
Interest and investment income
१.९४ लाख
१.९४ लाख
३.३८ लाख
३.३८ लाख
Interest expense
-३०.७६ लाख
-३०.७६ लाख
-७२.७५ लाख
-७२.७५ लाख
Net interest expenses
-२८.८२ लाख
-२८.८२ लाख
-६९.३६ लाख
-६९.३६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-५७.९० लाख
-५७.९० लाख
-८८.४१ लाख
-८८.४१ लाख
Gain or loss from assets sale
७६.५० हजार
७६.५० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू